Canisius Wilhelmina Ziekenhuis

At Canisius Wilhelmina Ziekenhuis in Nijmegen, clinical trials in hematology focus on improving care for a wide range of blood cancers and related disorders, including acute myeloid leukemia, chronic lymphocytic leukemia, diffuse large B-cell lymphoma, follicular lymphoma, multiple myeloma, and myelodysplastic syndrome. The research is aimed at testing new treatment combinations, refining existing therapies, and improving outcomes for patients with difficult-to-treat disease.

• Acute myeloid leukemia and myelodysplastic syndrome studies evaluating newer treatment combinations for patients who need better first-line options
• Chronic lymphocytic leukemia, small lymphocytic lymphoma, and follicular lymphoma trials exploring more effective targeted and immune-based treatments
• Multiple myeloma research focused on treatment duration, disease control, and maintaining benefit after therapy changes

These studies reflect a strong effort to advance blood cancer therapy through better disease control, improved tolerability, and more personalized treatment strategies.

The site has a major research focus on urothelial cancer and prostate cancer, including muscle-invasive bladder cancer, non-muscle-invasive bladder cancer, upper tract urothelial carcinoma, and metastatic castration-resistant prostate cancer. These trials are designed to improve cancer control, support better surgical planning, and evaluate whether new treatment approaches can extend survival or reduce recurrence.

• Bladder cancer and urothelial carcinoma studies testing new bladder-preserving and perioperative treatment strategies
• Prostate cancer trials assessing next-generation hormonal treatments and ways to improve disease control
• Upper tract urothelial carcinoma research looking at the best timing and use of chemotherapy around surgery

This research area combines treatment innovation with efforts to reduce unnecessary procedures and improve quality of life for patients with genitourinary cancers.

Trials in cardiology and vascular medicine at this hospital examine major conditions such as atherosclerotic cardiovascular disease, myocardial infarction, atrial fibrillation, stroke, and peripheral arterial disease. Several studies also address lipid disorders, obesity, and type 2 diabetes, with the goal of preventing serious cardiovascular events and improving long-term risk management.

• Atherosclerotic cardiovascular disease studies evaluating new ways to lower the risk of heart attack and stroke
• Myocardial infarction and heart failure research focused on improving recovery after acute cardiac events
• Peripheral arterial disease and stroke trials exploring more personalized prevention strategies

Overall, the cardiovascular program emphasizes prevention, risk reduction, and better long-term outcomes for people with high cardiometabolic risk.

Another important research theme is respiratory disease, including asthma, chronic obstructive pulmonary disease, pneumonia, acute respiratory distress syndrome, and lower respiratory tract infections. The trials aim to improve symptom control, reduce complications, and test whether new therapies can help patients recover more effectively from severe lung illness.

• Asthma and COPD studies evaluating better prevention of flare-ups and longer-term disease control
• Pneumonia and acute respiratory infection research focused on improving outcomes in hospitalized patients
• ARDS trials exploring new supportive treatments for severe breathing failure

At Canisius Wilhelmina Ziekenhuis, this field brings together pulmonary medicine and infectious disease research to address both chronic and acute respiratory illness.

Clinical research also covers several neurological and pain-related disorders, including migraine, cluster headache, dystonic tremor syndrome, and status epilepticus. These studies are mainly aimed at improving symptom relief, preventing attacks, and understanding which treatments work best for different patient groups.

• Migraine studies testing preventive options for adults and children
• Cluster headache research evaluating approaches to reduce attack frequency and improve day-to-day functioning
• Dystonic tremor work examining how treatment response relates to clinical and imaging features

This area highlights a practical focus on symptom management and quality of life for patients living with long-term neurological conditions.

The site contributes to studies in women’s health and reproductive medicine, including infertility, polycystic ovary syndrome, contraception, pregnancy-related complications, and vulvar high-grade squamous intraepithelial lesion. The purpose of this research is to improve fertility outcomes, support safer care in reproductive health, and reduce the chance of disease recurrence.

• Infertility and subfertility trials looking at ways to improve the chance of pregnancy and live birth
• Polycystic ovary syndrome and hormonal health studies addressing reproductive and metabolic concerns
• Vulvar HSIL research focused on preventing recurrence after treatment

These trials show a broad commitment to reproductive health research and more effective care for women with complex gynecologic conditions.

Clinical trials at the site also extend into musculoskeletal disease, hormonal disorders, and broader internal medicine topics such as obesity, type 2 diabetes, and coagulopathy. These studies often aim to compare standard treatments with newer options, improve long-term disease control, or reduce the need for more invasive care.

• Osteoarthritis studies evaluating ways to delay joint replacement and ease pain
• Hormonal disease research addressing conditions such as late-onset hypogonadism
• Metabolic disease trials focused on better management of obesity and diabetes

This diverse portfolio reflects the hospital’s role as a multidisciplinary research center with studies that span everyday chronic illness as well as specialized care.